S'abonner

Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter - 08/09/11

Doi : 10.1016/S0002-9149(99)00276-3 
Shih-Huang Lee, MD b, Ching-Tai Tai, MD a, Wen-Chung Yu, MD a, Yi-Jen Chen, MD a, Ming-Hsiung Hsieh, MD a, Chin-Feng Tsai, MD a, Mau-Song Chang, MD a, Shih-Ann Chen, MD a,
a Division of Cardiology, Department of Medicine, National Yang-Ming University, Veterans General Hospital-Taipei, Taiwan, China 
b Shin Kong Wu Ho-Su Memorial Hospital, Taiwan, China 

*Address for reprints: Shih-Ann Chen, MD, Division of Cardiology, Veterans General Hospital-Taipei, 201 Sec. 2, Shih-Pai Road, Taipei, Taiwan, Republic of China

Abstract

The long-term effects of radiofrequency catheter ablation on quality of life in patients with typical atrial flutter are still unknown. This study included 100 consecutive patients with clinically documented typical atrial flutter. Subjective perception of quality of life was assessed by a semiquantative questionnaire before, and 1 and 6 months after ablation. Ablation of typical atrial flutter was associated with a significant improvement in the general quality of life, frequency of significant symptoms, and symptoms during attacks. The frequency of hospital admission and emergency room visits, and number of antiarrhythmic drugs significantly decreased after ablation. Activity capacity significantly improved after ablation in patients with depressed left ventricular function. All improvements after ablation were maintained over 6-month follow-up. However, patients with atrial fibrillation compared with those without atrial fibrillation before ablation had less improvement in the general quality of life, frequency of significant symptoms, and symptoms during attacks (including palpitation, asthenia, effort, dyspnea, rest dyspnea, and dizziness). Furthermore, patients with atrial fibrillation before ablation needed more antiarrhythmic drugs, and had a higher frequency of hospital admission and emergent room visits at 6-month follow-up (all variables p <0.01). Multivariate analysis demonstrated that only the presence of atrial fibrillation before ablation could independently predict improvement in general quality of life (p = 0.03), frequency of significant symptoms (p = 0.03), symptoms during attacks (p = 0.04), and decrease in the consumption of health care resources including antiarrhythmic drugs (p = 0.01), hospital admission (p = 0.02), and emergency room visits (p = 0.02). Ablation of typical atrial flutter could significantly improve quality of life, but patients who had atrial flutter associated with atrial fibrillation before ablation had less improvement than those without atrial fibrillation.

Le texte complet de cet article est disponible en PDF.

Plan


 This study was supported in part by grants from the National Science Council (NSC 87-2314-B-010-058, 87-2314-B-010-059, 87-2314-B-075-070, 87-2314-B-075-071), Veteran General Hospital (VGH-254, VGH-301), and Shin Kong Wu Ho-Su Memorial Hospital (SKH-8302-86-0126-01), Taipei, Taiwan, Republic of China.


© 1999  Excerpta Medica Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 84 - N° 3

P. 278-283 - août 1999 Retour au numéro
Article précédent Article précédent
  • Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter
  • David G Benditt, John H Williams, Judy Jin, Thomas F Deering, Robert Zucker, Kevin Browne, Peter Chang-Sing, Bramah N Singh, for the dl-Sotalol Atrial Fibrillation/Flutter Study Group
| Article suivant Article suivant
  • Reproducibility of head-up tilt testing potentiated with sublingual nitroglycerin in patients with unexplained syncope
  • Giovanni Foglia-Manzillo, Franco Giada, Sandro Beretta, Giovanni Corrado, Mauro Santarone, Antonio Raviele

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.